Drugs / Suduvax
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05422508 Comparator | Jul 2022 → Jun 2025 overdue | chickenpox | Green Cross Corporation | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Suduvax | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05422508 ↗ |
| Route | Subcutaneous | “0.5ml, single dose, subcutaneous injection” NCT05422508 ↗ |